Fixed combination dosage forms for the treatment of migraine

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/196 (2006.01) A61K 9/00 (2006.01) A61K 31/403 (2006.01) A61K 31/404 (2006.01) A61K 31/4045 (2006.01) A61K 31/4196 (2006.01) A61K 31/422 (2006.01) A61K 31/454 (2006.01) A61P 25/00 (2006.01) A61P 25/06 (2006.01) A61P 27/00 (2006.01)

Patent

CA 2661819

Therapeutic regimens and dosage forms are disclosed for the treatment of migraine headache. The regimens preferably combine a serotonin receptor agonist, such as sumatriptan, eletriptan or almotriptan, with a fast acting formulation of diclofenac potassium.

La présente invention concerne des régimes et des formes posologiques thérapeutiques destinés au traitement de la migraine. De préférence, les régimes combinent un agoniste des récepteurs de la sérotonine, tel que le sumatriptan, l'élétriptan ou l'almotriptan, avec une formulation à action rapide de diclofénac potassique.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Fixed combination dosage forms for the treatment of migraine does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Fixed combination dosage forms for the treatment of migraine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fixed combination dosage forms for the treatment of migraine will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2091314

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.